| Literature DB >> 31660117 |
Divya Karuppannasamy1, Raghuram Andavar1, Jayavardhana Arumugam2, Kumaresan Muthuvel3.
Abstract
PURPOSE: Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a rare, life-threatening multi-system adverse drug reaction characterized by febrile skin rash, hematologic abnormalities, and involvement of internal organs. We report a case of DRESS syndrome in a child presenting with primary ophthalmic manifestations. CASE REPORT: An 11-year-old boy presented with severe pain and diminished vision in both eyes six weeks after starting carbamazepine therapy for seizure disorder. Ocular examination revealed features of bilateral acute anterior uveitis, acute onset myopia, and angle closure glaucoma secondary to uveal effusion. Additionally, the patient was febrile with a generalized maculopapular rash, and blood investigations revealed eosinophilic leukocytosis. A diagnosis of carbamazepine-induced DRESS syndrome was made, and carbamazepine therapy was discontinued. Treatment with cycloplegics, topical, and systemic steroids resulted in prompt clinical recovery.Entities:
Keywords: Carbamazepine; DRESS Syndrome; Anterior Uveitis
Year: 2019 PMID: 31660117 PMCID: PMC6815337 DOI: 10.18502/jovr.v14i3.4795
Source DB: PubMed Journal: J Ophthalmic Vis Res ISSN: 2008-322X
Diagnostic criteria for DRESS syndrome
|
| ||
|
|
|
|
| All the three criteria are required | Typical DRESS: all the seven criteria are required Atypical DIHS: only the first five are required | Presence of more than three of the following criteria |
| 1. Cutaneous drug eruption | 1. Maculopapular rash developing three weeks after the treatment with the offending drug | 1. Hospitalization |
| 2. Hematologic abnormalities: Eosinophils | 2. Prolonged clinical symptoms after discontinuing the causative drug | 2. Acute rash |
| 3. Systemic involvement: lymphadenopathy | 3. Fever | 3. Reaction suspected to be drug-related |
| 4. Hepatic abnormalities (ALT | 4. Fever | |
| 5. Leukocytosis, eosinophils | 5. Lymphadenopathy involving at least two sites | |
| 6. Lymphadenopathy | 6. Involvement of one internal organ (liver, kidney, or others) | |
| 7. Reactivation of HHV-6 | 7. Hematologic abnormalities: lymphocyte count above or below normal limits, eosinophil count above laboratory limits, platelet count below laboratory limits. | |
| ALT, Alanine transaminase; DIHS, drug-induced hypersensitivity syndrome; HHV, human herpes virus | ||